Caricamento...
Lorcaserin decreases the reinforcing effects of heroin, but not food, in rhesus monkeys
Preclinical studies indicate that lorcaserin (Belviq®), an FDA-approved serotonin 2C receptor agonist, may be a promising medication for the treatment of stimulant addiction. However, few studies have investigated its effects on self-administration of drugs of abuse from other pharmacological classe...
Salvato in:
| Pubblicato in: | Eur J Pharmacol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6219614/ https://ncbi.nlm.nih.gov/pubmed/30268662 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2018.09.025 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|